News + Publications
HRH the Crown Prince and Prime Minister meets with the Chairman of China National Pharmaceutical Group Corporation (Sinopharm)
His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, today met with the Chairman of China National Pharmaceutical Group Corporation (Sinopharm), Liu Jingzhen, at Gudaibiya Palace. His Royal Highness highlighted the importance of internationally coordinated efforts to meet global health challenges, noting the Kingdom’s commitment to supporting initiatives to […]
Read MoreParents’ views on the acceptability of a COVID-19 vaccine for their children: A cross-sectional study in Abu Dhabi-United Arab Emirates
The United Arab Emirates had approved the COVID-19 vaccine for children. Assessing parents’ acceptance of the vaccine for their children will influence decision-making in the COVID-19 vaccine roll-out.
Read MorePathological sequelae of long-haul COVID
The world continues to contend with successive waves of coronavirus disease 2019 (COVID-19), fueled by the emergence of viral variants.
Read MoreWhen Vaccine Apathy, Not Hesitancy, Drives Vaccine Disinterest
Even before COVID-19 vaccines were available, different interest levels in vaccination across the US were noted.
Read More
Sinopharm advances in Fortune Global 500
The UAE ambassador to China, His Excellency Dr. Ali Obaid Al Dhaheri congratulated SINOPHARM, a Hayat Biotech shareholder, for advancing in the Fortune Global 500 list of the largest companies in the world, from ranking 109th in 2021 to the 80th rank this year.
Read More